Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2004-07-30
Original market date: See footnote 1
1999-07-13
Product name:
PENTA-BROMAZEPAM TABLETS
DIN:
02232556 Electronic product monograph is not available
Company:
PENTAPHARM LTD.
3 Glendinning Ave.
Toronto
Ontario
Canada
M1W 3E2
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Targeted (CDSA IV)
American Hospital Formulary Service (AHFS): See footnote 3
28:24.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
N05BA08 BROMAZEPAM
Active ingredient group (AIG) number:See footnote5
0114488003
Active ingredient(s) | Strength |
---|---|
BROMAZEPAM | 3 MG / TAB |